US Patent 11293927 Screening methods for PARP modulators
Patent 11293927 was granted and assigned to Ribon Therapeutics on April, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11293927 Screening methods for PARP modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
